Repligen - 31 Year Stock Price History | RGEN

Historical daily share price chart and data for Repligen since 1990 adjusted for splits. The latest closing stock price for Repligen as of October 27, 2021 is 271.04.
  • The all-time high Repligen stock closing price was 324.21 on September 23, 2021.
  • The Repligen 52-week high stock price is 327.32, which is 20.8% above the current share price.
  • The Repligen 52-week low stock price is 162.29, which is 40.1% below the current share price.
  • The average Repligen stock price for the last 52 weeks is 217.13.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Repligen Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 223.3039 190.6600 324.2100 165.8700 271.0400 41.44%
2020 135.1351 93.7800 206.5700 84.9600 191.6300 107.17%
2019 74.5097 51.6900 95.5100 49.4500 92.5000 75.39%
2018 46.6978 37.0600 68.8800 30.9200 52.7400 45.37%
2017 36.9658 31.1500 46.0600 28.8200 36.2800 17.72%
2016 27.8137 28.1000 33.9800 20.9300 30.8200 8.94%
2015 31.9389 20.1000 42.1400 19.8600 28.2900 42.88%
2014 18.9447 12.6300 25.4900 12.3000 19.8000 45.16%
2013 9.2758 6.6300 13.6400 5.9800 13.6400 117.20%
2012 4.9963 3.5000 7.2600 3.4200 6.2800 80.98%
2011 3.7511 4.5200 5.3400 3.1100 3.4700 -26.01%
2010 3.5501 4.0400 4.7500 3.1300 4.6900 14.11%
2009 4.6107 3.9200 5.5500 3.5600 4.1100 8.73%
2008 5.0503 6.6500 6.8600 3.3000 3.7800 -42.29%
2007 3.9288 2.8000 6.5500 2.8000 6.5500 133.10%
2006 3.3184 3.9000 4.9900 2.2700 2.8100 -29.75%
2005 2.5936 2.9000 4.0000 1.6700 4.0000 38.89%
2004 2.4385 4.1600 4.1600 1.3200 2.8800 -34.10%
2003 5.1840 2.9700 8.2610 2.7600 4.3700 43.75%
2002 2.7848 2.6900 4.3800 2.1100 3.0400 24.79%
2001 2.8083 3.5630 5.6560 1.3400 2.4360 -27.82%
2000 6.6213 3.0630 16.6300 3.0000 3.3750 8.00%
1999 2.7662 1.3750 4.7500 1.2500 3.1250 143.95%
1998 1.3729 1.0310 3.0000 0.9688 1.2810 63.96%
1997 1.1450 1.2190 1.7500 0.7188 0.7813 -34.34%
1996 1.1393 1.0600 1.5625 0.5000 1.1900 5.78%
1995 1.7766 1.8750 3.0630 1.0000 1.1250 -35.71%
1994 4.1901 7.0000 8.0000 1.7500 1.7500 -74.55%
1993 7.2480 9.5000 10.5000 5.5000 6.8750 -27.63%
1992 12.7509 17.0000 20.1300 8.0000 9.5000 -38.71%
1991 14.3425 12.0000 29.0000 10.3800 15.5000 24.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $15.034B $0.366B
Repligen Corporation is a life sciences company focused on the development, production and commercialization of high-value consumable products used in the process of manufacturing biological drugs. Their bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. They are a leading manufacturer of Protein A, a critical reagent used to separate and purify monoclonal antibody therapeutics. They also supply several growth factor products used to increase cell culture productivity during the fermentation stage of drug manufacturing. In addition, they have developed and marketed their OPUS? series of pre-packed `plug-and-play` chromatography columns, and they provide test kits to ensure final product quality. Aside from their core bioprocessing business, they have a portfolio of clinical-stage partnering assets, including a pancreatic imaging agent in Phase 3 development and an orphan drug candidate in Phase 1 development.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.416B 8.62
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.526B 21.21
Biohaven Pharmaceutical Holding (BHVN) United States $9.249B 0.00
Emergent Biosolutions (EBS) United States $2.705B 6.53
Arcus Biosciences (RCUS) United States $2.404B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.873B 0.00
Myovant Sciences (MYOV) United Kingdom $1.831B 0.00
Zymeworks (ZYME) Canada $1.080B 0.00
Ambrx Biopharma (AMAM) United States $0.464B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.161B 15.86